VALCIP
Brand:
VALCIP
Manufacturer:
CIPLA
Manufacturer Details
CIPLA
Compositions:
Valganciclovir hcl 450mg tablets,
|
Strength
|
Rate
|
Packing Style
|
|
450mg
|
3620.00
|
10s tablets
|
List of Related Indications:
- CMV Retinitis - Cytomegaovirus rhinitis
List Of Drugs:
- Valganciclovir - Ant-viral
Indication Type Description:
Indication:
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Valganciclovir powder for 09-10-2009
Oral solution 50mg/ml
For the Treatment of Cytomegalovirus (CMV) Retinitis in Aids Patients
and for prevention of CMV disease in solid organ Transplant patients at
High Risk
2.Valganciclovir For CMV 20-11-2003
Dosages/ Overdosage Etc:
For the Treatment of Cytomegalovirus (CMV) Retinitis in Aids Patients
and for prevention of CMV disease in solid organ Transplant patients at
High Risk
